BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29343221)

  • 21. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
    Rutkauskiene G; Labanauskas L
    Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy.
    Hartsell WF; Gajjar A; Heideman RL; Langston JA; Sanford RA; Walter A; Jones D; Chen G; Kun LE
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):15-24. PubMed ID: 9300735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy with procarbazine, vincristine and prednisone for medulloblastomas. A preliminary report.
    Seiler RW; Bernasconi S; Berchtold W; Feldges A; Imbach P; Lüthi A; Plüss HJ; Vassella F; Wyss M; Wagner HP
    Helv Paediatr Acta; 1981 Jul; 36(3):249-54. PubMed ID: 7275674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of genomic aberrations during clinical progression of medulloblastoma.
    Korshunov A; Benner A; Remke M; Lichter P; von Deimling A; Pfister S
    Acta Neuropathol; 2008 Oct; 116(4):383-90. PubMed ID: 18704466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Extraneural Metastatic Medulloblastoma in an Adult Presenting With a Superscan and Treated With Radium-223.
    Mou B; Cruz-Lim EM
    Cureus; 2023 Feb; 15(2):e34732. PubMed ID: 36909024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete remission and long-term survival in a child with relapsed medulloblastoma with extensive osteosclerotic bony metastasis with a novel metronomic chemobiological approach.
    Sondhi V; Arun Kurkure P; Jalali R; Rangarajan V; Sridhar E; Medhi S; Arora B
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):e195-8. PubMed ID: 22258352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of extraneural metastasis of medulloblastoma successfully treated with cisplatin and etoposide].
    Kanai H; Nagai H; Mabe H; Wakabayashi S; Yamashita N
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):545-7. PubMed ID: 1558405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttreatment Maturation of Medulloblastoma into Gangliocytoma: Report of 2 Cases.
    Mullarkey MP; Nehme G; Mohiuddin S; Ballester LY; Bhattacharjee MB; Trivedi D; Shah MN; Fuller GN; Zaky W; Sandberg DI
    Pediatr Neurosurg; 2020; 55(4):222-231. PubMed ID: 32882694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone metastases in medulloblastoma--single institution experience.
    Nikitović M; Bokun J; Paripović L; Golubičić I; Grujičić D; Sopta J
    Pediatr Hematol Oncol; 2013 Mar; 30(2):80-91. PubMed ID: 23301509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
    Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
    Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
    Rutkowski S; Bode U; Deinlein F; Ottensmeier H; Warmuth-Metz M; Soerensen N; Graf N; Emser A; Pietsch T; Wolff JE; Kortmann RD; Kuehl J
    N Engl J Med; 2005 Mar; 352(10):978-86. PubMed ID: 15758008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A preliminary report.
    Venes JL; McIntosh S; O'Brien RT; Schwartz AD
    J Neurosurg; 1979 Jun; 50(6):721-4. PubMed ID: 438873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
    Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
    Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
    Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
    Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
    Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
    J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy for medulloblastoma.
    McIntosh S; Chen M; Sartain PA; Duncan C; Fishburn R; Klatskin EH; Schwartz AD; Venes JL
    Cancer; 1985 Sep; 56(6):1316-9. PubMed ID: 4027871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
    Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.